期刊文献+

糖尿病神经病变的药物治疗

下载PDF
导出
摘要 醛糖还原酶抑制剂可抑制氧化应激导致的炎症;联合抗抑郁药物阿米替林、抗惊厥药拉莫三嗪、非甾体抗炎药、阿片类药物吗啡、选择性5-羟色胺再摄取抑制剂及5-羟色胺/去甲肾上腺再摄取抑制剂等多种药物,极少患者能达到疼痛完全缓解;自主神经病变的对症治疗包括:胃轻瘫、心律失常,膀胱自主神经病变、男性性功能障碍。
出处 《药品评价》 CAS 2011年第19期14-16,41,共4页 Drug Evaluation
  • 相关文献

参考文献15

  • 1Nathan DM,Cleary PA,Backlund JY,et al.Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DTTC/EDIC) Study Research Group.Intensive diabetes treatment and cardiovascular disease in patients with type t diabetes[J].N Engl J Med,2005,353:2643-2653.
  • 2Jain SK.Lim G Pyridoxine and pyridoxamineinhibits superoxide radicals and prevents lipid peroxidation,protein glycosylation,and(Na+-K+)-ATPase activity reduction In high glucose-treated human erythrocytes[J].Free Radie Bid Med,2001,30:232.237.
  • 3Scott K,Zeris S,Kothari MJ.Elevated B6 levels and peripheral neuropathies this[J].Electromyogr Clin Neurophysiol,2008,48(5):219-223.
  • 4Pittenger G,Vinik A.Nerve growth factor and diabetic neuropathy[J].Exp Diabesity Res,2003,4:271.285.
  • 5Mahmood D,Singh BK,Akhtar M.Diabetic neuropathy:therapies on the horizon[J].J Pharm Pharmtacol,2009,61(9):1137-1145.
  • 6Palacka P,Kucharska J,Murin J,et al.Complementary therapy in diabetic patients with chronic complications:a pilot study[J].Bratisl Lek Listy,2010,111(4):205-211.
  • 7Winkler G,Kempler P.Pathomechanism of diabetic neuropathy:background of the pathogenesis-oriented therapyp[J].Orv Hetil,2010,151(24):971.981.
  • 8Srivastava SK,Yadav UC,Reddy AB,et al.Aldose Reductase Inhibition Suppresses Oxidative Stress-Induced Inflammatory Disorders[J].Chem Biol Interact,2011 Feb 24.
  • 9Maladkar M,Rajadhyaksha G,et al.Efficacy,safety,and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy[J].Int J Diabetes Dev Ctries,2009,29(1):28-34.
  • 10Mahmood D,Singh BK,Akhtar M.Diabetic neuropathy:therapies on the horizon[J].J Pharm Pharmacol,20109,61(9):1137-1145.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部